
|Articles|April 15, 2010
Clearstate and United BioSource Corporation Launch Strategic Partnership
Advertisement
Clearstate Pte. Ltd.
and
United BioSource Corporation (UBC)
announced a strategic partnership to provide global market access, pricing, and reimbursement strategies for manufacturers of biopharmaceuticals, medical devices, and other medical technology.
The agreement reinforces Clearstate’s position as a source for accurate and actionable market intelligence across the Asia-Pacific region and builds upon UBC’s leadership in delivering global market access strategies for life science products. The alliance provides UBC and its clients with access to the high quality market access, pricing, and reimbursement information.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
2
Why Patient Input Comes in Too Late—and What Earlier Engagement Changes
3
Lab Orchestration Is Not What You Think It Is
4
Recruitment in the Age of AI: Q&A with John Worden, Javara
5



